Anthem Biosciences Limited has informed the Exchange regarding Notice of Postal Ballot
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anthem Biosciences has issued a postal ballot notice seeking shareholder approval through remote e-voting (August 14 to September 12, 2025). Three resolutions are on the table: ratification of the Employee Stock Option Plan 2024 (ESOP 2024) covering up to 1,14,09,700 options, extension of ESOP 2024 benefits to subsidiary employees, and approval of remuneration for two employees who are relatives of directors. ESOP 2024 was originally approved on June 10, 2025, before the company's listing on BSE and NSE on July 21, 2025, and now needs post-listing ratification as per SEBI rules. The related party remuneration proposed for FY 2025-26 totals ₹1.51 crore — ₹1.2 crore for Ishaan Bhardwaj (Senior Management Personnel) and ₹31 lakh for Krithika G (Deputy Manager), both relatives of directors. Voting results will be announced on or before September 15, 2025.
This is a routine governance exercise. ESOP ratification enables the company to continue granting stock options to attract and retain talent post-IPO, which could lead to minor equity dilution over time. The related party remuneration, while relatively small, uses a portion of promoter-family compensation and may draw attention from governance-focused investors.